Trade Trade

Comment: EU merger reviews continue but will be hampered by Covid-19 crisis

By Natalie McNelis and Nicholas Hirst
  • 27 Mar 2020 09:55
  • 27 Mar 2020 09:55

Dealmakers had some cause for cheer from the EU merger regulator this week, as it made clear it would continue to review the bulk of transactions knocking at its door.

The decision to open an in-depth review into Johnson & Johnson’s purchase of TachoSil (see here) is the latest sign that,

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Natalie McNelis

Senior Correspondent

Natalie McNelis covers mergers for MLex in Brussels. Before joining MLex in 2017, she spent 20 years as an international trade and competition lawyer in law firms including Stibbe and WilmerHale. Natalie has a BA in English from Mount Holyoke College, a JD from Harvard Law School and an LLM in EU law from KU Leuven. She is admitted to the bar in New York.

Nicholas Hirst

Chief Correspondent

Nicholas covers EU merger review and antitrust investigations for Mlex in Brussels. He previously wrote about EU affairs for Politico Europe, European Voice and PaRR. After earning an LLM in European law from the College of Europe in Bruges, he spent a year working in the competition practice of a leading competition law firm in Brussels 2009-10. He graduated in modern European languages from Oxford University in 2006.

Discover MLex

Stay on top of global regulatory developments

Latest News